Free CME from PeerView


Genetics CME

Credits: 2.0 CME / MOC
Purdue University
Accelerating Progress in the Treatment of Alzheimer’s Disease: How Can We Achieve Timely and Accurate Neuropathological Diagnosis and Precision Management of Mild Cognitive Impairment in Early Alzheimer’s Disease?
Liana G. Apostolova, MS, MD, FAAN
March 18, 2022
Credits: 0.5 CME / NCPD
Medical Learning Institute, Inc.
Breakthroughs in Spinal Muscular Atrophy: Managing the Life-Changing Impact of Gene Replacement Therapy
Julie Parsons, MD
March 01, 2022
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Putting the Pieces Together: Would You Recognize Acute Hepatic Porphyria If You Saw It?
Herbert L. Bonkovsky, MD
February 25, 2022
Credits: 1 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Making New Strides in Hypertrophic Cardiomyopathy: The Latest Guidelines, Science, and Strategies for Early Diagnosis and Tailored Treatment
Neal K. Lakdawala, MD / Anjali Tiku Owens, MD
November 13, 2021
Credits: 1 CME / MOC / CC
Medical Learning Institute, Inc.
Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLC: Refining and Expanding Best Practices in Advanced and Early-Stage Disease Settings
Lynette M. Sholl, MD
October 29, 2021
Credits: 0.5 CME
Medical Learning Institute, Inc.
On the Cusp of a New Targeted Treatment Era in ALS: Exploring the Emerging Therapeutic Landscape
Professor Dame Pamela J. Shaw
October 22, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Heart Failure Society of America
Easing the Burden of Hypertrophic Cardiomyopathy: Progress in Understanding and Addressing Its Pathophysiology
Daniel Jacoby, MD
October 01, 2021
Medical Learning Institute, Inc.
Target Practice: Understanding How PARP Inhibitors Take Aim at DNA Damage Response Mutations Across Solid Tumors
Susana Banerjee, MBBS, MA, FRCP, PhD
May 07, 2021
Medical Learning Institute, Inc.
Acute Hepatic Porphyria: Disease Diagnosis and Revelations Regarding the Role of siRNA Therapy
Karl E. Anderson, MD
April 15, 2021
Medical Learning Institute, Inc.
New Milestones and Changing Standards of Care in EGFR-Mutated NSCLC: Expanding the Benefits of Genomic Testing and EGFR-Targeted Therapy to Early-Stage Lung Cancer
March 09, 2021
Medical Learning Institute, Inc.
Targeting DNA Repair Defects Through PARP Inhibition in Prostate Cancer: Rationale, Evidence, and Clinical Implications
Emmanuel S. Antonarakis, MD
July 22, 2020

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView